$HROW

Harrow, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Nashville, TN

HROW chart

What traders are saying about $HROW

Latest posts

Harrow, Inc. news

Harrow, Inc. key financials

USD2025202420232022
Revenue$272.3M$199.6M$130.2M$88.6M
Net income-$5.1M-$17.5M-$24.4M-$14.1M
Diluted EPS$-0.14$-0.49$-0.75$-0.51
Total assets (year end)$399.5M$389.0M$312.2M$157.4M
Cash and equivalents (year end)$72.9M$47.2M$74.1M$96.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Harrow, Inc.

Ticker
HROW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Nashville, TN
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1360214
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC

Frequently asked questions

What exchange is Harrow, Inc. listed on?

Harrow, Inc. trades on the Nasdaq under the ticker symbol HROW.

What industry is Harrow, Inc. in?

Harrow, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Harrow, Inc. headquartered?

Harrow, Inc.'s business address on file with the SEC is in Nashville, TN.

When does Harrow, Inc.'s fiscal year end?

Harrow, Inc.'s fiscal year ends on December 31.

How much revenue did Harrow, Inc. report?

Harrow, Inc. reported $272.3M in revenue for calendar year 2025, according to its SEC filings.